For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Point-of-care Diagnostics (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
Scope of the Report:
Currently, there are more companies enter into POC Diagnostics industry in the world, especially in USA. The main market players are, Alere, Roche, Abbott Laboratories, Johnson & Johnson, Siemens Healthcare, Danaher, Bayer Healthcare, Beckman Coulter, etc.
Alere is the largest supplier of POC Diagnostics, with the revenue market share about 18% in 2015, and the top 6 supplier of POC Diagnostics, with the revenue market share about 68% in 2015. That is to say, the industry of POC Diagnostics is relative concentration.
There are nine kinds of POC Diagnostics, which are Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Tumor Markers Testing, Urinalysis Testing and Cholesterol Testing. Blood Glucose Testing is wildly used in the POC Diagnostics, with a revenue market share nearly 46% in 2015. The fastest-growing segment, Cardiac Markers Testing, is projected to increase at a CAGR of 13%.
POC Diagnostics is used in Clinics, Hospitals, Laboratory and Others. Report data showed that 42.3% of the POC Diagnostics market demand in Clinics application, 34.4% in Hospitals application, and 4.9% in Laboratory application in 2015.
Development Tendency
Briefly speaking, in the next few years, POC Diagnostics industry will still be a highly energetic industry. Revenue of POC Diagnostics have brought a lot of opportunities there will more companies enter into this industry, especially in developing countries.
The worldwide market for POC Diagnostics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the POC Diagnostics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Alere
- Roche
- Abbott Laboratories
- Johnson & Johnson
- Siemens Healthcare
- Danaher
- Bayer Healthcare
- Beckman Coulter
- Nipro Diagnostics
- Bio-Rad Laboratories
- Nova Biomedical
- BioMerieux
- Quidel
- Helena Laboratories
- OraSure Technologies
- Accriva
- Abaxis
- Chembio Diagnostics
- Trinity Biotech
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Blood Glucose Testing
- Infectious Diseases Testing
- Cardiac Markers Testing
- Coagulation Testing
- Pregnancy and Fertility Testing
- Blood Gas/Electrolytes Testing
- Tumor Markers Testing
- Urinalysis Testing
- Cholesterol Testing
Market Segment by Applications, can be divided into
- Clinics
- Hospitals
- Laboratory
- Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe POC Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of POC Diagnostics, with price, sales, revenue and global market share of POC Diagnostics in 2017 and 2018.
Chapter 3, the POC Diagnostics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the POC Diagnostics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, POC Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe POC Diagnostics sales channel, distributors, customers, research findings and conclusion, appendix and data source.